ActivePure Targets HAIs in Healthcare

DALLAS -- ActivePure Medical, a provider of continuous air and surface decontamination technology for healthcare, has announced the results of a pioneering study that showed reduced surface and air contamination from its Induct Guardian Series of products.

Published in the American Journal of Infection Control, the study demonstrates the significant impact of ActivePure Technology, showing a 96-99% reduction in methicillin-resistant Staphylococcus aureus (MRSA) and a 70% decrease in total healthcare-associated infections (HAIs) across two hospitals.

This medical-grade, proprietary environmental decontamination technology aims to complement existing infection control measures in hospital settings by providing continuous automated protection. ActivePure Medical, a division of AP Sciences Group, LLC, is a provider of proactive, continuous surface and air decontamination systems for healthcare.

The research, conducted across intensive care units at two major hospitals – Ochsner Health Center-West Bank, Gretna, LA, and Lexington Veterans Affairs (VA) Healthcare System, Troy Bowling Campus, Lexington, KY – revealed significant and persistent reductions in surface and air contamination following installation of the Induct Guardian Series air decontamination system with ActivePure Technology.

“As someone who has dedicated my career to safeguarding public health, I cannot overstate the profound impact ActivePure Medical's simultaneous air and surface decontamination technology could have in our relentless battle against healthcare-associated infections,” said Dr. Deborah Birx, Chief Medical & Science Advisor at AP Sciences Group, LLC, and former White House Coronavirus Response Coordinator.

“I have witnessed firsthand the devastating toll HAIs exact on patients, their families, the healthcare system and society. By providing continuous, proactive decontamination of surfaces and air, the Induct Guardian Series air decontamination system targets the very environmental reservoirs that sustain preventable infections, offering a new, much-needed defense to systematically suppress their propagation.

“The unprecedented reductions in surface and air contamination, coupled with the substantial declines in observed infections hold remarkable potential to enhance patient safety, alleviate the economic burden posed by these infections and ultimately save countless lives.”

The significant microbial reductions in the treated hospital spaces after activation of ActivePure Technology translated into substantially lower incidence of HAIs at both study sites compared to baseline, offering compelling evidence that continuous environmental decontamination can meaningfully enhance patient safety.

At Ochsner Health, total aggregate HAIs declined by 71% over a 21-month period, while the Lexington VA site saw HAIs fall by 70% over 12 months. Notably, the study demonstrated a 96-99% reduction in mean surface MRSA and fungal levels across both facilities.

The Centers for Disease Control and Prevention (CDC) estimates that there are approximately 722,000 HAIs and 75,000 HAI-related deaths per year in the U.S. HAIs lead to significant human suffering, including early deaths, debilitation and lost productivity.

Beyond the immeasurable personal toll, they also result in unnecessary direct medical costs of at least $28.4 billion annually, with additional societal costs amounting to another $12.4 billion.

ActivePure Technology works by replicating indoors the same atmospheric cleansing processes found in outdoor air. This proprietary technology produces powerful oxidizing molecules that safely disable pathogens both in the air and on surfaces, running continuously to provide crucial automated protection against environmental contamination risks.

“These studies confirm that current manual disinfection practices, despite dedicated cleaning protocols, still leave patients exposed to persistent reservoirs of deadly pathogens,” said Joseph P. Urso, Chief Executive Officer of AP Sciences Group, LLC. “By providing an automated, continuous layer of added protection, our medical grade technology delivered unprecedented reductions in concerning organisms driving preventable infections across these intensive care units. These aren't just poignant statistics; they represent a pivotal advancement in safeguarding vulnerable patients and healthcare staff.”

While advancements in cleaning and disinfection protocols have been made, HAIs continue to occur.
ActivePure Technology aims to address this critical issue. It provides 24/7 proactive and automated full-facility disinfection of surfaces and air. By targeting missed and neglected surfaces, preventing recontamination, and improving air quality, ActivePure Medical’s air-driven decontamination system using ActivePure Technology contributes to reducing the spread of pathogens and enhancing infection control in healthcare settings.

For more information, go to ActivePure.com/healthcare.